Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06550674

Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
Centre Jean Perrin · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Only 20% of familial uveal melanomas are explained by a hereditary predisposition, implying the presence of as yet unknown hereditary predispositions. This hypothesis is reinforced by epidemiological studies revealing an excess risk of prostate cancer, thyroid cancer and leukemia in patients who have developed uveal melanoma, even though these cancers are not part of the tumor spectrum of known hereditary predispositions to uveal melanoma (BAP1, MBD4). The identification of new candidate genes, once validated, would enable us to offer these families appropriate surveillance.

Conditions

Interventions

TypeNameDescription
GENETICConstitutional exome analysisFor each patient included: * A family tree is drawn up, reporting personal and family histories of cancer. The patient's anatomopathological reports, related to his or her tumor lesions, are retrieved, in order to confirm/clarify individual or family diagnoses. * A blood sample and a jugal smear are taken to enable constitutional genetic exome analysis for research purposes.

Timeline

Start date
2024-10-29
Primary completion
2028-04-01
Completion
2028-04-01
First posted
2024-08-13
Last updated
2026-03-19

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT06550674. Inclusion in this directory is not an endorsement.

Identification of New Candidate Genes for Hereditary Predisposition to Uveal Melanoma (NCT06550674) · Clinical Trials Directory